The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study-Reference-Cited by-同舟云学术

The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study

Published:2013-01-03 Issue:1 Volume:73 Page:132-137
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Fagerli Karen Minde,Lie Elisabeth,van der Heijde Désirée,Heiberg Marte Schrumpf,Lexberg Åse Stavland,Rødevand Eric,Kalstad Synøve,Mikkelsen Knut,Kvien Tore K

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference22 articles.

1. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial;Antoni;Ann Rheum Dis,2005

2. Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression;Mease;Arthritis Rheum,2004

3. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial;Mease;Lancet,2000

4. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial;Mease;Arthritis Rheum,2005

5. Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: twenty-four-week efficacy and safety results of a randomized, placebo-controlled study;Kavanaugh;Arthritis Rheum,2009

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment with Targeted Therapy in Patients with Psoriatic Arthritis and Inadequate Response to Methotrexate: Proposal for a Rational Strategy;Rheumatology and Therapy;2024-08-12

2. Efficacy and Safety of Bimekizumab in Patients With Psoriatic Arthritis With or Without Methotrexate: 52‐Week Results From Two Phase 3 Studies;ACR Open Rheumatology;2024-07-30

3. No difference in clinical parameters and drug retention in PsA patients receiving b/tsDMARD monotherapy versus combination with methotrexate: data from the RABBIT-SpA registry;RMD Open;2024-07

4. Psoriasis and Related Disorders;Rook's Textbook of Dermatology;2024-03-19

5. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update;Annals of the Rheumatic Diseases;2024-03-18